NOVO-B:CPH
Novo Nordisk A/S
DKK 253.85
arrow_downward
-1.91%(-4.95) 1D
Sep 23, 3:52:13 PM GMT+2 · DKK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVO-B...
Open
DKK 256.00
High
DKK 260.45
Low
DKK 253.55
Mkt. cap
877.37B
Avg. vol.
4.60M
Volume
2.51M
52-wk high
DKK 409.95
52-wk low
DKK 224.25
Shares outstanding
3.39B
No. of employees
67K
Open
DKK 256.00
High
DKK 260.45
Low
DKK 253.55
Mkt. cap
877.37B
Avg. vol.
4.60M
Volume
2.51M
52-wk high
DKK 409.95
52-wk low
DKK 224.25
Shares outstanding
3.39B
No. of employees
67K
News stories
From web sources and news partners
MarketBeat
·
39 minutes ago
Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?
Yahoo Finance
·
1 hour ago
Novo Nordisk Stock Slides After Unveiling Long Term Pipeline Growth Targets
Simply Wall Street
·
3 hours ago
Novo Nordisk (NVO) Stock Still Looks Cheap On Earnings Today
Financial Times
·
9 hours ago
Ozempic maker Novo open to upgrading New York listing
Profile
Novo is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish companies, which date back to the 1920s.
Novo employs approximately 48,000 people globally, and markets its products in 168 countries. Novo is controlled by majority shareholder Novo Holdings which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights, while spin-off company Novozymes was named fourth. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
About Novo Nordisk A/S
CEOMaziar Mike Doustdar
Employees66.7K
FoundedDec 21, 1923
HeadquartersBagsværd, Capital Region of Denmark, Denmark
SectorPharmaceutical industry
Websitenovonordisk.com